Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red network_comparison green
Results: HTML CSV LaTeX Showing element 51 to 100 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-12 subunit. [source:swissprot;acc:q9ubi6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1833.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.0534\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
892.67\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-4 subunit. [source:swissprot;acc:p50150]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1834.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04922\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
895.134\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-3 subunit. [source:swissprot;acc:p29798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1834.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04912\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
895.194\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
necdin. [source:swissprot;acc:q99608]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-8 subunit (gamma-9). [source:swissprot;acc:q9uk08]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1834.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04858\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
895.507\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 subunit. [source:swissprot;acc:p30670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1834.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
895.633\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-10 subunit. [source:swissprot;acc:p50151]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1834.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04827\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
895.697\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1834.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04793\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
895.893\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1835.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04611\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
896.972\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02382\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.546\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02378\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.564\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.741\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02339\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.763\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02337\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.774\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02312\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.903\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02297\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.978\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d2 (mage-d2 antigen) (breast cancer associated gene 1 protein) (bcg-1) (11b6) (hepatocellular carcinoma associated protein jcl-1). [source:swissprot;acc:q9unf1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1836.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02297\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
907.978\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trophinin. [source:swissprot;acc:q12816]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18263\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5359.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1857.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.93827\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
958.237\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5359.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1881.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.83093\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1027.36\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
28136.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5321.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
33457.6\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 1 (transducin beta chain 1). [source:swissprot;acc:p04901]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1931.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.82652\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1057.39\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 4 (transducin beta chain 4). [source:swissprot;acc:q9hav0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1926.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.82448\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1056.02\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 7; sds22. [source:refseq;acc:nm\_002712]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
27642.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5202.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
22440.4\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 4, 30kd subunit; cleavage-polyadenylation specificity factor, 30kd; no arches-like (zebrafish) zinc finger protein; cleavage-polyadenylation specificity factor. [source:refseq;acc:nm\_006693]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4464.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase-dna-binding protein 3 (chd-3) (mi-2 autoantigen 240 kda protein) (mi2-alpha). [source:swissprot;acc:q12873]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trs85 homolog. [source:swissprot;acc:q9y2l5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24896.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4464.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
20431.7\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein wdc146. [source:swissprot;acc:q9c0j8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
24806.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4437\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
20369.9\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specificity factor, 100 kda subunit (cpsf 100 kda subunit) (fragment). [source:swissprot;acc:q9p2i0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24473.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4346.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
20127.8\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/